Efficacy, Usability Study of the GlucoTab System for Glycaemic Management in Type 2 Diabetic Patients at General Wards

Inclusion Criteria: * Informed consent obtained after being advised of the nature of the study * Male or female aged ≥18 years * Type 2 diabetes (treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four) or newly diagnosed hyperglycaemia which requires s.c. insulin therapy Exclusion Criteria: * Type 1 diabetes, gestational diabetes * Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient * Pregnancy * Any mental condition rendering the patient incapable of giving his consent * Known or suspected allergy to insulin glargine or insulin aspart * Continuous parenteral nutrition * Participation in another trial which can influence the software algorithm